As there are few SOD1 ALS-associated mutations that directly prevent disulfide formation (C146R and truncation mutants), ebselen is likely to be effective for MBR mutants as well as WTL (2). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.